[Federal Register Volume 68, Number 10 (Wednesday, January 15, 2003)]
[Notices]
[Page 2074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-771]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated June 24, 2002, and published in the Federal 
Register on July 10, 2002, (67 FR 45765), Roche Diagnostics 
Corporation, 9115 Hague Road, Indianapolis, Indiana 46250, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocanabinols (7370)................  I
Alphamethadol (9605).......................  I
Cocaine (9041).............................  II
Benzoylecgonine (9180).....................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to import the listed controlled substances to 
manufacture controlled substances for use in drug abuse testing kits.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Roche Diagnostics Corporation to 
import listed controlled substances is consistent with the public 
interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Roche Diagnostic Corporation on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. These investigation have included inspection 
and testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to section 1008(a) of the Controlled Substances 
Import and Export Act and in accordance with Title 21, Code of Federal 
Regulations, Section 1301.34, the above firm is granted registration as 
an importer of the basis classes of controlled substances listed above.

    Dated: December 13, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-771 Filed 1-14-03; 8:45 am]
BILLING CODE 4410-09-M